The Coface Country Risk Conference, currently at its 13th edition it is considered a catalyst of ideas and debates within the national business community.
The event became a traditional risk management event in Romania and a point of reference for the leading representatives of local and international business environment.
In 2016, the event brought together an important number of participants, over 350 experts in country risk, academic and banking specialists and Romanian and foreign investors.
On this occasion, leading experts in economics and business environment will discuss the hot topics of the moment: the economic future of the European Union and Romania’s situation within this context, local economic trends, strategies and policies for a healthy business environment.
During the first session, we will discuss the implications of global economic risks in emerging and developed countries and the main trends that shape today's economy. Invite this session are experts in macroeconomics and country risk. Our lecturers are experts in macroeconomics and country risk.
The second session of the Conference is structured as a debate, and the theme is the suitable strategies and policies for a sustainable business environment in Romania.
“I would recommend this conference to my business community, because it helps you with information regarding both national and international level." - Renania Trade.
“The high qualities of the attendees, the diversity, were the strengths of this edition.” - Piraeus Bank
Speakers:Ay?en Seltem ?Y?GÜN, Chief Economist, Coface Turkey & Middle EastEugen ANICESCU, Country Manager, Coface RomâniaHans BUYSSE, Chairman, The Belgian Association of Financial Analysts & Member and Treasurer, EFFAS Executive Management Committee & Member, XBRL Europe Executive CommitteeModerator:Cristian HOSTIUC, Editorial Director, Ziarul Financiar
Speakers:Daniela LULACHE, CEO, Nuclearelectrica SARobert REKKERS, CEO, Agricover Credit IFNMihai MIRON, CEO, Ropharma*M?riuca TALPE?, CEO, Intuitext & CEO, Bitdefender*Bogdan ION, Country Managing Partner, EY Romania & MoldovaModerator:Iancu GUDA, CFA, EMBA, Services Director, Coface Romania & President, AAFBR
Eugen Anicescu started his career in 2001 within Generali Insurance, as Head of Insurance.
Starting from 2007, he is working within Coface Romania, and he owned, over time, more strategic positions, such as Credit Insurance Manager during April 2007 - January 2011 and Deputy Managing Director, during January 2011 - September 2012.
In October 2012, he was appointed Managing Director and he held this position until March 2016.
Eugen Anicescu graduated The Bucharest University of Economic Studies and he holds a Business Administration Master Degree within the same university.
With over 25 years’ experience, Robert Rekkers is a respectable banker in the Romanian finance sector, being awarded as “The annual banker” in 2010 and 2011 in the Gala Financial Market publication. Robert Rekkers was CEO of Transilvania Bank for more than 9 years, and during this time, he brought the bank from a position of small local player in the top 3 in Romania. Before that, he worked for 16 years in ABN AMRO, having various senior management positions in 7 countries. Since July 2012, Mr. Rekkers joined the Board of Directors of the Group Agricover and became CEO of Credit IFN Agricover. Its objective is to develop and grow it in order to become the leading financial institution in financing farmers and consequently the Romanian agriculture.
Mihai Miron is one of the oldest entrepreneurs on the pharmaceutical market, being the founder of Europharm, company that sold it towards GlaxoSmithKline. He created and launched on the Romanian market 82 medicines, including the famous Paracetamol Sinus, Paracetamol Plus and Omeran. Also, started with 2003, he is President of Bioef SRL, Administrator of Bioterra starting with 1998 and Chairman of the Board of ICS Eurofarmaco SA Chisinau. He obtained Ph.D at the University of Medicine and Pharmacy "Iuliu Hatieganu" Cluj Napoca, Faculty of Pharmacy, Department of Pharmaceutical Technology and Biopharmaceutics.